Ratios Revealed: Decoding Seres Therapeutics Inc (MCRB)’s Financial Health

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

The closing price of Seres Therapeutics Inc (NASDAQ: MCRB) was $1.11 for the day, down -6.72% from the previous closing price of $1.19. In other words, the price has decreased by -$6.72 from its previous closing price. On the day, 6.17 million shares were traded. MCRB stock price reached its highest trading level at $1.25 during the session, while it also had its lowest trading level at $1.06.

Ratios:

Our analysis of MCRB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 1.78.

On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.

Goldman Downgraded its Neutral to Sell on July 23, 2021, whereas the target price for the stock was revised from $24 to $7.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 16 ’24 when Shaff Eric D. sold 11,549 shares for $1.08 per share. The transaction valued at 12,473 led to the insider holds 135,321 shares of the business.

Ege David S. sold 5,010 shares of MCRB for $5,411 on Feb 16 ’24. The insider now owns 73,856 shares after completing the transaction at $1.08 per share. On Feb 16 ’24, another insider, von Moltke Lisa, who serves as the insider of the company, sold 4,400 shares for $1.08 each. As a result, the insider received 4,752 and left with 16,988 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 167619984 and an Enterprise Value of 253591504. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.33. Its current Enterprise Value per Revenue stands at 2.007 whereas that against EBITDA is -2.493.

Stock Price History:

Over the past 52 weeks, MCRB has reached a high of $6.26, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 31.24%, while the 200-Day Moving Average is calculated to be -36.23%.

Shares Statistics:

MCRB traded an average of 4.50M shares per day over the past three months and 6478050 shares per day over the past ten days. A total of 135.04M shares are outstanding, with a floating share count of 119.44M. Insiders hold about 20.91% of the company’s shares, while institutions hold 44.21% stake in the company. Shares short for MCRB as of 1713139200 were 17634355 with a Short Ratio of 3.92, compared to 1710460800 on 18397627. Therefore, it implies a Short% of Shares Outstanding of 17634355 and a Short% of Float of 16.360001.

Most Popular

[the_ad id="945"]